Back to search

Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones

Data up to Jan 2025

Published1991
Citations128
References28

Total Citations Per Year

Abstract

References (28)

Antibiotics in Laboratory Medicine.

1980 • 2,763 citations

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1985 • 694 citations

Fluoroquinolone antimicrobial agents

1989 • 633 citations

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

1987 • 486 citations

Antibiotics in laboratory medicine

1986 • 332 citations

Killing and regrowth of bacteria in vitro: a review.

1990 • 301 citations

Evaluation of Intravenous Ciprofloxacin in Patients With Nosocomial Lower Respiratory Tract Infections

1989 • 169 citations

Clinical Pharmacokinetics of the Newer Antibacterial 4-Quinolones

1988 • 140 citations

Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models.

1990 • 135 citations

Effect of Salt Concentration on the Apparent In-Vitro Susceptibility of Pseudomonas and Other Gram-Negative Bacilli to Gentamicin

1971 • 132 citations

The mode of action of 4-quinolones and possible mechanisms of resistance

1986 • 123 citations

The postantibiotic effect

1986 • 117 citations

Interactions of Fluoroquinolones with Other Drugs: Mechanisms, Variability, Clinical Significance, and Management

1992 • 113 citations

Selection of Aminoglycoside-Resistant Variants of Pseudomonas aeruginosa in an in Vivo Model

1982 • 109 citations

Human pharmacodynamics of beta-lactams, aminoglycosides and their combination.

1990 • 86 citations

Correlation of pharmacokinetic parameters to efficacy of antibiotics: relationships between serum concentrations, MIC values, and bacterial eradication in patients with gram-negative pneumonia.

1990 • 78 citations

Occult Aminoglycoside Resistance in Pseudomonas aeruginosa: Epidemiology and Implications for Therapy and Control

1985 • 67 citations

The Importance of Pharmacodynamics in Determining the Dosing Interval in Therapy for Experimental Pseudomonas Endocarditis in the Rat

1986 • 56 citations

Pulse Dosing Versus Continuous Infusion of Antibiotics

1988 • 49 citations

Combination Therapy with Ciprofloxacin plus Azlocillin against Pseudomonas aeruginosa: Effect of Simultaneous versus Staggered Administration in an In Vitro Model of Infection

1991 • 46 citations

Comparative study on antagonistic effects of low pH and cation supplementation on in-vitro activity of quinolones and aminoglycosides against Pseudomonas aeruginosa

1988 • 42 citations

Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin

1986 • 31 citations

Efficacy of ciprofloxacin in stationary-phase bacteria in vivo.

1987 • 27 citations

Single daily dosing of amikacin in an in-vitro model

1991 • 24 citations

Effect of dose and schedule on cefoperazone pharmacodynamics in an in Vitro model of infection in a neutropenic host

1988 • 21 citations

Impact of the antibiotic dosage schedule on efficacy in experimental lung infections.

1990 • 16 citations

A review of the pharmacokinetic profile of temafloxacin

1991 • 11 citations

Abhängigkeit von Bakterizidie und Mutantenselektion bei 4-Chinolonen von deren Serumkonzentrationsverläufen

1986 • 9 citations

Cited By (0)

Loading...